These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37152037)
1. Necroptosis-related lncRNAs: establishment of a gene module and distinction between the cold and hot tumors in glioma. Cao K; Su F; Shan X; Jiang X; Ni Z; Chen Y Front Oncol; 2023; 13():1087117. PubMed ID: 37152037 [TBL] [Abstract][Full Text] [Related]
2. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs. Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H Front Immunol; 2022; 13():916800. PubMed ID: 35860239 [TBL] [Abstract][Full Text] [Related]
3. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer. Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J J Oncol; 2021; 2021():6718443. PubMed ID: 34790235 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
5. Necroptosis-associated long noncoding RNAs can predict prognosis and differentiate between cold and hot tumors in ovarian cancer. He YB; Fang LW; Hu D; Chen SL; Shen SY; Chen KL; Mu J; Li JY; Zhang H; Yong-Lin L; Zhang L Front Oncol; 2022; 12():967207. PubMed ID: 35965557 [TBL] [Abstract][Full Text] [Related]
6. A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma. Xia P; Huang Y; Chen G Front Oncol; 2022; 12():940220. PubMed ID: 36033510 [TBL] [Abstract][Full Text] [Related]
7. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma. Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S Front Genet; 2022; 13():862741. PubMed ID: 35368663 [No Abstract] [Full Text] [Related]
8. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer. Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X Front Genet; 2022; 13():984696. PubMed ID: 36092933 [No Abstract] [Full Text] [Related]
9. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma. Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A Front Genet; 2022; 13():916024. PubMed ID: 36110223 [No Abstract] [Full Text] [Related]
10. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma. Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472 [TBL] [Abstract][Full Text] [Related]
11. N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors. Wu JY; Song QY; Huang CZ; Shao Y; Wang ZL; Zhang HQ; Fu Z Front Genet; 2022; 13():952836. PubMed ID: 35937987 [No Abstract] [Full Text] [Related]
12. Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma. Jiang F; Zhan Z; Yang Y; Liu G; Liu S; Gu J; Chen Z; Wang Z; Chen G J Oncol; 2022; 2022():5681206. PubMed ID: 36065303 [TBL] [Abstract][Full Text] [Related]
13. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer. Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H Front Genet; 2022; 13():938250. PubMed ID: 36561319 [No Abstract] [Full Text] [Related]
14. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma. Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976 [No Abstract] [Full Text] [Related]
15. Comprehensive Analysis of Necroptosis Landscape in Skin Cutaneous Melanoma for Appealing its Implications in Prognosis Estimation and Microenvironment Status. Cao X; He J; Chen A; Ran J; Li J; Chen D; Zhang H J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836481 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients. Chen D; Dou C; Liu H; Xu B; Hu B; Kuang L; Yao J; Zhao Y; Yu S; Li Y; Wang F; Guo M Front Oncol; 2022; 12():929233. PubMed ID: 36033536 [TBL] [Abstract][Full Text] [Related]
17. Necroptosis-Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor-Infiltrating Lymphocytes in Breast Cancer. Tao S; Tao K; Cai X J Oncol; 2022; 2022():7099930. PubMed ID: 35528236 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma. Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432 [TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma. Mo J; Cui Z; Wang Q; Zhang W; Li J; Wu S; Qian W; Zhou C; Ma Q; Wang Z; Wu Z Front Genet; 2022; 13():940794. PubMed ID: 36051690 [TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma. Zeng C; Yu H; Liu X; Liu Q; Jin J Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]